News by Tag: Lipid Market


Generics to account for more than 92% of the US Dyslipidemia market by 2016
August 22, 2011
A new report from IMARC Group expects the volume share of generic drugs in the US Dyslipidemia market to reach levels worth more than 92% by 2016.